Measles, Mumps, Rubella and Varicella Virus Vaccine Live Injection, ProQuad
Last Updated: November 14, 2012
Products Affected - Description
There are no presentations affected.
Reason for the Shortage
- Merck cannot provide a reason for the shortage.1
- Merck is the sole manufacturer of this combination product.
ProQuad single dose vials (NDC 00006-4999-00), Merck
Estimated Resupply Dates
Merck has ProQuad available.1
Implications for Patient Care
ProQuad is used to simultaneously vaccinate children 12 months to 12 years of age against measles, mumps, rubella, and varicella.2
Do not mix MMR-II and Varivax in the same syringe during this shortage.2
Alternative Agents & Management
Clinicians must use the single component vaccines MMR-II and Varivax during this shortage.1
- BCG Vaccine Live Intravesical — Current
- Hepatitis A Virus Vaccine Inactivated — Resolved
- Hepatitis B Vaccine Recombinant — Resolved
- Hepatitis B Vaccine Recombinant and Bivalent Haemophilus influenzae type B conjugate — Resolved
- Rabies Vaccine — Resolved
- Typhoid Vi Polysaccharide Injectable Vaccine — Resolved
- Yellow Fever Vaccine Injection — Current
- Zoster Vaccine Live — Resolved
- Merck, (personal communication). February 26, March 5, May 29, July 10 and 23, 2007; February 11, August 18, 2008; February 11, June 1, June 23, September 1, November 30, 2009; January 21, February 3, March 26, May 4 and 10, June 14, July 26, August 11, September 10, September 22, 2010; March 14, June 7, August 30, October 14, and December 12, 2011; February 8, April 10, June 29, August 29, October 2, and November 14, 2012.
- ProQuad (Measles, Mumps, Rubella, and Varicella Virus Vaccine Live) [product information]. West Point, PA: Merck; 2006, July.
Updated November 14, 2012 by Leslie Jensen, PharmD, Drug Information Specialist. Created March 6, 2007 by Erin R. Fox, PharmD, Drug Information Specialist. Copyright 2012, Drug Information Service, University of Utah, Salt Lake City, UT.